Joseph Nolan
Director Ejecutivo en Jaguar Gene Therapy LLC .
Fortuna: 88 $ al 30/04/2024
Origen de la red de primer grado Joseph Nolan.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
Jaguar Gene Therapy LLC
 Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Jaguar Gene Therapy LLC is a company that aims to accelerate breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company is based in Lake Forest, IL. The company's unrelenting commitment is to advocate boldly and care fiercely for patients and families. The company works together to confront the challenges of treating complex diseases and are advancing their initial pipeline that targets diseases with significant unmet need in sizeable patient populations. Joseph Nolan has been the CEO of the company since 2020.
11
| Holding Company | Medical/Nursing Services | 11 |
| Public Company | Biotechnology | 7 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Joseph Nolan a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
Deerfield Management Co. LP (Private Equity)
 Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management Co. LP (Private Equity) (Deerfield) is a private equity subsidiary of Deerfield Management Co. LP founded in 1994. The firm is headquartered in the New York. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| TERNS PHARMACEUTICALS, INC. | Biotechnology | Chairman Director/Board Member | |
| BIOTIE THERAPIES CORP | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| TAYSHA GENE THERAPIES, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| INTERMUNE INC | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Apertura Gene Therapy LLC
 Apertura Gene Therapy LLC BiotechnologyHealth Technology Apertura Gene Therapy LLC is a next-generation gene therapy company that is advancing gene therapies developed on their high-throughput platforms. The company is based in New York, NY. The company is expanding on the promise of gene therapy by building on advances in vector biology and protein engineering. Through AAV capsid engineering, they aim to accelerate therapies to patients living with genetic diseases. The company was founded by Ben Deverman. Joseph W. la Barge has been the CEO of the company since 2022. | Biotechnology | Director/Board Member | |
| RIGEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Harvard Law School | College/University | Graduate Degree | |
| Tufts University School of Medicine | College/University | Doctorate Degree | |
Acorda Therapeutics Ltd.
 Acorda Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Acorda Therapeutics Ltd. operates as a biopharmaceutical company. It manufactures pharmaceutical preparations and performs research and experimental development. The company was incorporated on March 03, 2009 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | President | |
| SELLAS LIFE SCIENCES GROUP, INC. | Pharmaceuticals: Major | Chairman | |
Sellas Life Sciences Group Ltd.
 Sellas Life Sciences Group Ltd. Pharmaceuticals: MajorHealth Technology Sellas Life Sciences Group Ltd. manufactures pharmaceutical products. It focuses on innovative products to treat cancer and central nervous system diseases. The firm’s product candidate, licensed from Memorial Sloan-Kettering Cancer Center is a late-stage innovative WT1-targeting synthetic heteroclitic epitope immunotherapeutic in development for hematological malignancies and solid tumors characterized by an overexpression of the WT1 (Wilms Tumor Protein) antigen. The company was founded by Angelos M. Stergiou in 2012 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Chairman | |
Cytovia Therapeutics, Inc.
 Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
New York Biotechnology Association, Inc.
 New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
| UCB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| University of Cape Town | College/University | Doctorate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| United States Senate | General Government | Corporate Officer/Principal | |
| Princeton University | College/University | Undergraduate Degree | |
| University of South Africa | College/University | Undergraduate Degree | |
| University of Maryland | College/University | Undergraduate Degree | |
| John Carroll University | College/University | Director/Board Member | |
| REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Encoded Therapeutics, Inc.
 Encoded Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Encoded Therapeutics, Inc. operates as a biotechnology company that engages in the development of precision medicines and therapy for genetic disorders. It focuses on viral gene therapies. The company was founded by Kartik Ramamoorthi and Stephanie Tagliatela and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Chairman | |
| VENTAS, INC. | Real Estate Investment Trusts | Director/Board Member | |
Istari Oncology, Inc.
 Istari Oncology, Inc. BiotechnologyHealth Technology Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC. | Biotechnology | Chairman | |
| ACORDA THERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel | |
Lundbeck, Inc.
 Lundbeck, Inc. Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck, Inc. is a pharmaceutical company that produces pharmaceutical preparations. The company is based in Paramus, NJ. The company was founded by Jeffrey S. Aronin. | Pharmaceuticals: Major | President | |
Affinia Therapeutics, Inc.
 Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Biotechnology | Chairman | |
| Nolan Capital LLC | Chairman | ||
| SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. II | Financial Conglomerates | Director/Board Member | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
Ondek Pty Ltd.
 Ondek Pty Ltd. Pharmaceuticals: MajorHealth Technology Ondek Pty Ltd. develops natural immune modulatory products for allergic disorders. It offers ImmBALANCE, a product for allergy indications. The firm develops core ingredient for products that will reduce the allergic response in children, adolescents and adults. The company was founded by Barry Marshall in 2005 and is headquartered in Sydney, Australia. | Pharmaceuticals: Major | Director/Board Member | |
| Rhodes University | College/University | Undergraduate Degree | |
| CommunityHealth NFP | Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 40 |
| Sudafrica | 4 |
| Reino Unido | 3 |
| Finlandia | 2 |
| Bermudas | 2 |
Sectorial
| Health Technology | 31 |
| Consumer Services | 11 |
| Finance | 6 |
| Commercial Services | 3 |
| Government | 2 |
Operativa
| Director/Board Member | 107 |
| Independent Dir/Board Member | 33 |
| Corporate Officer/Principal | 28 |
| Chairman | 15 |
| Undergraduate Degree | 15 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Jonathan Leff | 45 |
| Ismail Kola | 26 |
| Sean Nolan | 18 |
| David Fellows | 16 |
| Jack Wyszomierski | 15 |
| Philip Donenberg | 15 |
| Jane Wasman | 14 |
| Andrew Knudten | 10 |
| Elise T. Wang | 10 |
| David Greenwald | 8 |
| Daniel Camardo | 7 |
| Neema Mayhugh | 5 |
| Maia Hansen | 5 |
| Elise Wang | 5 |
| Dave Greenwald | 2 |
- Bolsa de valores
- Insiders
- Joseph Nolan
- Conexiones Empresas